Komipharm International Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 20, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	506,393	506,943	267,413	293,942	446,056	548,450
Market Cap Growth	27.76%	89.57%	-9.03%	-34.10%	-18.67%	-36.13%
Enterprise Value	524,586	522,408	289,788	324,970	476,056	565,527
Last Close Price	7000.00	7020.00	3860.00	4190.00	6350.57	7804.20
PE Ratio	-	-	20.39	-	-	-
PS Ratio	10.13	9.66	4.55	6.89	11.21	15.30
PB Ratio	6.91	7.04	4.08	4.90	6.80	7.58
P/TBV Ratio	7.32	7.47	4.43	5.22	7.36	8.26
P/FCF Ratio	-	-	34.28	-	-	-
P/OCF Ratio	-	-	30.23	-	-	-
EV/Sales Ratio	10.49	9.96	4.93	7.62	11.96	15.78
EV/EBITDA Ratio	117.75	108.86	31.18	-	21308.58	-
EV/EBIT Ratio	299.39	266.47	46.79	-	-	-
EV/FCF Ratio	-	-	37.14	-	-	-
Debt / Equity Ratio	0.55	0.56	0.67	0.75	0.58	0.46
Debt / EBITDA Ratio	9.03	8.48	4.72	-	1706.78	-
Debt / FCF Ratio	-	-	5.62	-	-	-
Net Debt / Equity Ratio	0.21	0.18	0.33	0.51	0.42	0.27
Net Debt / EBITDA Ratio	3.52	2.66	2.30	-11.04	1223.16	-11.41
Net Debt / FCF Ratio	-3.40	-3.45	2.74	-8.81	-10.29	-9.42
Asset Turnover	0.39	0.41	0.49	0.37	0.35	0.30
Inventory Turnover	2.18	2.39	2.52	1.93	1.87	1.77
Quick Ratio	0.84	0.86	0.83	0.52	0.53	0.93
Current Ratio	1.31	1.30	1.30	0.96	1.01	1.61
Return on Equity (ROE)	-10.39%	-11.67%	23.40%	-9.41%	-10.84%	-7.89%
Return on Assets (ROA)	0.85%	0.95%	3.21%	-3.40%	-2.09%	-2.79%
Return on Capital Employed (ROCE)	2.10%	2.40%	8.10%	-9.50%	-5.40%	-5.90%
Earnings Yield	-1.26%	-1.42%	4.90%	-1.35%	-1.46%	-0.81%
FCF Yield	-0.91%	-0.73%	2.92%	-1.17%	-0.60%	-0.38%
Buyback Yield / Dilution	-20.48%	-1.41%	0.57%	0.18%	-0.01%	-0.09%